Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CNR2


Brief Information

Name:Cannabinoid CB2 receptor
Target Synonym:CX5,CNR2,CB-2,Cannabinoid Receptor 2,Cannabinoid Receptor 2 (Macrophage),CB2,Testis-Dominant CNR2 Isoform CB2,CB2A,CB2B,HCB2,Receptor, Cannabinoid, CB2
Number of Launched Drugs:2
Number of Drugs in Clinical Trials:13
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CN2-H52P5 Human Human CNR2 Full Length Protein (VLP)
ACRO Quality

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Cannabidiol GWP-42003-P; BOL-DP-o-05; GW-42003; RLS-103; LYT-310; RAD011; GWP-42003; BTX-1204; ZYN-002; PTL-101; CHI-902; APH-1501; AVCN-583601; GLA-015; BTX-1503; BTX-1801; BTX-1702; PBX-1308; ART-12.11; ART-1211; RAD-011; BRCX-014 Approved Gw Pharmaceuticals Plc Epidyolex, Cannepil, Epidiolex, Zygel United States Epilepsies, Myoclonic; Lennox Gastaut Syndrome Gw Research Ltd 2018-06-25 Peripheral Nervous System Diseases; Substance-Related Disorders; HIV Infections; Sleep Initiation and Maintenance Disorders; Ovarian Neoplasms; Facial Pain; Migraine Disorders; Marijuana Smoking; Tobacco Use Cessation; Tobacco Smoking; Acne Vulgaris; Anxiety; Seizures; Schizophrenia; Pain; Autism Spectrum Disorder; Rett Syndrome; Brain Injuries, Traumatic; Inflammatory Bowel Diseases; Tuberous Sclerosis; Fatty Liver; Marijuana Abuse; Chronic Pain; Marijuana Use; Alcoholic Intoxication; Diabetes Mellitus, Type 2; Child Behavior Disorders; Appetitive Behavior; Diabetic Neuropathies; Chronic Urticaria; Opioid-Related Disorders; Coronavirus Disease 2019 (COVID-19); Hoarding Disorder; Musculoskeletal Pain; Psychotic Disorders; Neoplasms; Bipolar Disorder; Arthritis, Rheumatoid; Graft vs Host Disease; Brain Diseases; Blepharospasm; Sturge-Weber Syndrome; Glioblastoma; Dyspepsia; Sleep Wake Disorders; Hyperalgesia; Parkinsonian Disorders; Pancreatic Neoplasms; Multiple Sclerosis; Lennox Gastaut Syndrome; Azotemia; U Details
Cannabidiol/Dronabinol THC-5; delta-9-THC/CBD; MPL-001; MPL-005; GW-1000; KL16-012; BOL-DP-o-04; GW-1000-02; PPP-001; MGC-ODT Approved Gw Pharmaceuticals Sativex, Qixleef Canada Muscle Spasticity; Multiple Sclerosis; Neuralgia; Cancer Pain; Chronic Pain null 2005-04-01 Arthritis, Psoriatic; Phobia, Social; Urinary Bladder, Overactive; Tic Disorders; Reflex Sympathetic Dystrophy; Huntington Disease; Sciatica; Muscle Spasticity; Malnutrition; Acute Pain; Tourette Syndrome; Neuromyelitis Optica; Dementia; Neuralgia; Panic Disorder; Stress Disorders, Post-Traumatic; Hepatic Insufficiency; Osteoarthritis, Knee; Back Pain; Drug Resistant Epilepsy; Hidradenitis Suppurativa; Agoraphobia; Renal Insufficiency, Chronic; Social Behavior; Low Back Pain; Cerebral Palsy; Corticobasal degeneration; Depression; Peripheral Nervous System Diseases; Sleep Initiation and Maintenance Disorders; Pain; Anxiety; Spinal Cord Injuries; Cancer Pain; Chronic Pain; Marijuana Use; Spasm; Renal Insufficiency; Squamous Cell Carcinoma of Head and Neck; Marijuana Abuse; Depressive Disorder, Major; Migraine Disorders; Neoplasms; Diabetic Neuropathies; Arthritis, Rheumatoid; Anxiety Disorders; Kidney Diseases; Anorexia; Essential Tremor; Opioid-Related Disorders; Neck Pain; Sleep Wake Disorders; Multiple Scler Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Dronabinol(Vertanical) VER-01 Phase 3 Clinical Vertanical GmbH Low Back Pain Details
CNTX-6016 CNTX-6016 Phase 1 Clinical C.H. Boehringer Sohn Ag & Co. Kg Pain; Chronic Pain; Diabetic Neuropathies; Nociceptive Pain Details
Dronabinol(AXIM Biotechnologies) Phase 3 Clinical Axim Biotech Neoplasms; Vomiting; Child Nutrition Disorders; Nausea; Cachexia; Anorexia Nervosa; Sarcopenia Details
ZYN-001 ZYN-001 Phase 1 Clinical Zynerba Pharmaceuticals Neuralgia; Fibromyalgia Details
Cannabidiol/Palmitoylethanolamide THX-210; SCI–210 Phase 2 Clinical Therapix Biosciences Ltd Autism Spectrum Disorder; Diabetic Neuropathies Details
MP-10X MP-10X Clinical Medipure Holdings Pain Details
HU-308 PPP-003 Phase 1 Clinical Panag Pharma Pain; Retinal Diseases; Uveitis; Xerophthalmia; Ocular inflammation Details
Ajulemic acid HU-239; CPL-7075; CT-3; JBT-101; DMH-THC-11-OIC; DMH-11C; IP-751 Phase 3 Clinical Corbus Pharmaceuticals Holdings Inc Cystic Fibrosis; Lupus Vulgaris; Dermatomyositis; Lupus Erythematosus, Systemic; Scleroderma, Diffuse Details
NEO-1940 AZD-1940; NEO-1940; ART-2713; ART27.13 Phase 1 Clinical Astrazeneca Plc, Neomed Inc, Pfizer Inc Sleep Initiation and Maintenance Disorders; Cancer Pain; Anxiety; Nausea; Cachexia Details
C20T5 C20T5 Murdoch Childrens Research Institute Details
EHP-101 EHP-101; VCE-004; VCE-004.8 Phase 1 Clinical Emerald, Vivacell Biotechnology Multiple Sclerosis, Relapsing-Remitting; Scleroderma, Diffuse Details
Beta-Caryophyllene Phase 2 Clinical Hartford Hospital Pain Details
IPI 201(Isosceles Pharmaceuticals Inc ) IPI-201 Phase 1 Clinical Pain, Postoperative Details
Cannabidiol/hydroxychloroquine IHL-675A; IHL-675 Phase 2 Clinical Incannex Healthcare Ltd Arthritis, Rheumatoid; Respiratory Distress Syndrome, Adult Details
C12T12 C12T12 Murdoch Childrens Research Institute Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message